SMCI INVESTOR UPDATE: Super Micro Computer Investors that Lost Money are Notified to Contact BFA Law before October 29 Class Action Deadline (Nasdaq:SMCI)
September 21, 2024 07:16 ET
|
Bleichmar Fonti & Auld
Super Micro Computer investors that lost money on their investment are encouraged to contact BFA Law before the October 29, 2024 legal deadline.
BEN INVESTOR UPDATE: Franklin Resources, Inc. Investors are Notified to Contact BFA Law about Ongoing Investigation into the Company for Securities Fraud (NYSE:BEN)
September 21, 2024 07:16 ET
|
Bleichmar Fonti & Auld
Franklin Resources, Inc. investors that lost money on their investment are encouraged to contact BFA Law about their rights.
FORD INVESTOR UPDATE: Ford Motor Company Investors that Lost Money are Notified to Contact BFA Law before October 7 Class Action Deadline (NYSE:F)
September 21, 2024 07:16 ET
|
Bleichmar Fonti & Auld
Ford Motor Company investors that lost money on their investment are encouraged to contact BFA Law before October 7, 2024 legal deadline.
MXL INVESTOR UPDATE: MaxLinear, Inc. Investors are Notified to Contact BFA Law about Ongoing Investigation into the Company for Securities Fraud (Nasdaq:MXL)
September 21, 2024 07:16 ET
|
Bleichmar Fonti & Auld
MaxLinear investors that lost money on their investment are encouraged to contact BFA Law about their rights.
ABR INVESTOR UPDATE: Arbor Realty Trust, Inc. Investors that Lost Money are Notified to Contact BFA Law before September 30 Class Action Deadline (NYSE:ABR)
September 21, 2024 07:13 ET
|
Bleichmar Fonti & Auld
Arbor Realty Trust, Inc. investors that lost money on their investment are encouraged to contact BFA Law before September 30, 2024 legal deadline.
ME INVESTOR UPDATE: 23andMe Shareholders are Notified to Contact BFA Law about Ongoing Investigation into the Company for Breaches of Fiduciary Duties (Nasdaq:ME)
September 21, 2024 07:13 ET
|
Bleichmar Fonti & Auld
23andMe Holding Co. shareholders are encouraged to contact BFA Law about its investigation into the Board for breaches of fiduciary duties.
Teva Presents New Phase 3 Efficacy, Safety and Tolerability Data from SOLARIS Trial Evaluating TEV-‘749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable for Adult Patients Diagnosed with Schizophrenia
September 21, 2024 04:15 ET
|
Teva Pharmaceutical Industries Ltd
As a leader in neuroscience, Teva is committed to researching new treatment innovations that may help address unmet needs in treating schizophrenia, including TEV-‘749Currently, there is no...
New Data Provide Treatment Insights into Options for Switching Adult Patients Diagnosed with Schizophrenia to UZEDY® (risperidone) Extended-Release Injectable Suspension from Perseris® (RBP-7000)
September 21, 2024 04:10 ET
|
Teva Pharmaceutical Industries Ltd
As a leader in neuroscience, Teva remains committed to helping address unmet needs in the treatment of schizophrenia through scientific and clinical advances that support optimal treatment options and...
ACADIA HEALTHCARE COMPANY, INC. ANNOUNCEMENT: If You Have Suffered Losses in Acadia Healthcare Company, Inc. (NASDAQ: ACHC), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
September 20, 2024 21:17 ET
|
The Rosen Law Firm PA
NEW YORK, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Acadia...
ROSEN, A LEADING LAW FIRM, Encourages WEBTOON Entertainment Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – WBTN
September 20, 2024 21:07 ET
|
The Rosen Law Firm PA
NEW YORK, Sept. 20, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of WEBTOON Entertainment Inc. (NASDAQ: WBTN) pursuant and/or...